# Labetalol Hydrochloride

NDC: 10135-712
Generic name: Labetalol
Labeler / Manufacturer: Marlex Pharmaceuticals Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20201001

FDA application: ANDA075215

## Active ingredients

- LABETALOL: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10135-712"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10135-712
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28c91727-e5a8-48b3-a4df-d7bec8feda40